Clinical Trial Update: taVNS for Letter Learning in Dyslexia [NA]

View source ↗

Summary

The University of Florida is conducting a taVNS trial for letter learning in dyslexia. The study has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslexia

Snippet

Sponsor: University of Florida | Conditions: Dyslexia | NA | Status: SUSPENDED